Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid stage trial

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

Business - CNBC - 13 hours ago

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

Eli Lilly's quarter was messy. What to do with the stock is more clear-cut

We're upgrading our rating on the drugmaker to a buy-equivalent 1.

Business - CNBC - October 30

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - October 30

Jim Cramer identifies an interesting buy level for our worst performing Big Tech stock this year

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Business - CNBC - October 31

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.

Business - CNBC - October 30

Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Business - CNBC - November 8

How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS

Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.

Business - CNBC - 4 days ago

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.

Business - CNBC - 6 days ago

Putin returns to world stage hosting 36 leaders at Brics summit in Russia

West infuriated as UN secretary general accepts invitation to meeting of countries including China, India and Iran. Vladimir Putin, ostracised by the west and labelled a possible war criminal by ...

World - The Guardian - October 22

Christian McCaffrey nearing return: Why 49ers are poised for another second-half run with healthy All-Pro RB

San Francisco has an NFL-best 23-4 record in the second half of the season since 2021

Sports - CBS Sports - November 5

Eli Zabar’s Substack Night

A food king of Manhattan welcomes the newsletter crowd to a party celebrating the 50th anniversary of his Upper East Side cafe.

Lifestyle - The New York Times - 4 days ago

Judge declines to postpone Steve Bannon's trial on 'We Build the Wall' fraud charges

A New York judge has declined to immediately postpone Steve Bannon's Dec. 9 trial on charges that he defrauded supporters of the "We Build the Wall" fundraiser.

Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Election

Some women are stocking up on the medications, saying they are concerned that the new administration could take steps to restrict access.

Health - The New York Times - Yesterday

How to stay healthy during the holidays

Dr. Jon LaPook shares essential tips to help you stay healthy through the holiday season.

Abortion Pills Are Safe. Post-Roe America Isn’t.

In many states, hospitals are delaying or denying standard reproductive care.

Top stories - The New York Times - October 24

NHS offers 'improved' stop smoking pill

People in England will be able to get free varenicline tablets to help them quit cigarettes.

Amorim expects 'clarification' on his future on Friday

Manager Ruben Amorim says there will be "clarification" over his expected move to Manchester United after Sporting's game on Friday.

Two admit to rioting as Ely accused appear in court

The defendants started appearing in groups before Cardiff Crown Court on Monday, charged with riot.

Ron Ely, TV's 'Tarzan' in the 1960s, dies at 86

The tall, musclebound actor who played the title character in the 1960s NBC series “Tarzan,” Ron Ely's daughter says he died Sept. 29 in Los Alamos, California at age 86

Entertainment - ABC News - October 24

Tarzan star Ron Ely dies aged 86

The actor also appeared in hit 1980s television shows Wonder Woman and The Love Boat.

Verizon’s ‘healthy’ earnings are met with a shrug once again

Verizon’s stock is headed for its third post-earnings decline in a row.

Business - MarketWatch - October 22

Don’t be fooled by 'Make America Healthy Again'

The American people should not fall for Donald Trump’s latest con.

Politics - The Hill - November 4

Connor Bedard Continues To Impress Early In 2024-25

Connor Bedard is off to a fast start in 2024-25. The Chicago Blackhawks have a legit superstar in the making with him.

Sports - Yahoo Sports - October 21

How 'impressive' Southampton caused problems for Man City

Match of the Day pundit and ex-Southampton winger Theo Walcott analyses how Saints' style caused problems for Premier League champions Manchester City.

Poch impressed by USMNT's victory over Jamaica

Christian Pulisic scored twice for the United States national team in a 4-2 win over Jamaica on Monday night in their Concacaf Nations League quarterfinal.

Sports - ESPN - 8 hours ago

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Stephen Lillie on the neck-and-neck race to the finish line in the US election – cartoon

World - The Guardian - October 27

Lilly Sues U.S. to Change Hospital Drug Discount Payments

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.

Business - The Wall Street Journal - 4 days ago

Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients

The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

Business - The Wall Street Journal - October 21

Latest in Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid stage trial